HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GTP cyclohydrolase 1 downregulation contributes to glucocorticoid hypertension in rats.

Abstract
NO, a potent vasodilator, has been implicated in the pathogenesis of glucocorticoid hypertension. NO synthase requires the cofactor tetrahydrobiopterin for the production of NO. Guanosine-triphosphate (GTP) cyclohydrolase 1 is the rate-limiting enzyme for the production of tetrahydrobiopterin, and in the presence of low levels of tetrahydrobiopterin, NO production is decreased. We have previously shown that tetrahydrobiopterin-dependent vasodilation is impaired in rats with glucocorticoid hypertension. However, the role GTP cyclohydrolase 1 plays in the pathogenesis of glucocorticoid hypertension has not been investigated. Therefore, we tested the hypothesis that downregulation of GTP cyclohydrolase 1 contributes to the development and maintenance of glucocorticoid hypertension in rats. Rats were implanted with dexamethasone (0.79 mg x kg(-1) x d(-1)) or sham-operated, and systolic blood pressures were measured at baseline and after 12 hours, 4 days, or 15 days. Blood pressure increased significantly after dexamethasone treatment. Isometric force generation was measured in endothelium-intact aortic ring segments. Aortas from dexamethasone-treated rats exhibited a significant time-dependent decrease in maximal relaxation to acetylcholine compared with control rats. Incubation with sepiapterin (10(-4) mol/L, 1 hour), which produces tetrahydrobiopterin via a salvage pathway, restored vasodilation to acetylcholine in aortas from 4- and 15-day dexamethasone-treated rats. GTP cyclohydrolase 1 mRNA expression levels also significantly decreased in a time-dependent manner. These results support the hypothesis that downregulation of GTP cyclohydrolase 1 contributes to increased blood pressure in glucocorticoid hypertensive rats.
AuthorsBrett M Mitchell, Anne M Dorrance, R Clinton Webb
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 41 Issue 3 Pt 2 Pg. 669-74 (Mar 2003) ISSN: 1524-4563 [Electronic] United States
PMID12623977 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Glucocorticoids
  • RNA, Messenger
  • Dexamethasone
  • GTP Cyclohydrolase
Topics
  • Animals
  • Aorta (drug effects, physiopathology)
  • Blood Pressure
  • Dexamethasone (pharmacology)
  • Down-Regulation
  • Endothelium, Vascular (physiopathology)
  • GTP Cyclohydrolase (genetics, metabolism)
  • Gene Expression Regulation (drug effects)
  • Glucocorticoids (pharmacology)
  • Hypertension (chemically induced, enzymology, physiopathology)
  • Kinetics
  • Male
  • Organ Culture Techniques
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: